Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
D001792:Blood Platelets / Q000187:drug effects*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced / Q000628:therapy*; D006801:Humans; D008937:Mitomycins / Q000009:adverse effects*; D010956:Plasmapheresis
D008937:Mitomycins